Biodexa Pharmaceuticals (BDRX)
NASDAQ: BDRX
· Real-Time Price · USD
0.91
-0.01 (-1.13%)
At close: Jun 24, 2025, 12:30 PM
-1.13% (1D)
| Bid | 0.65 |
| Market Cap | 750 |
| Revenue (ttm) | 83K |
| Net Income (ttm) | -6.82M |
| EPS (ttm) | -13.56 |
| PE Ratio (ttm) | -0.07 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.92 |
| Volume | 145,503 |
| Avg. Volume (20D) | 2,541,375 |
| Open | 0.92 |
| Previous Close | 0.92 |
| Day's Range | 0.90 - 0.94 |
| 52-Week Range | 0.79 - 41.50 |
| Beta | 1.21 |
About BDRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BDRX
Website n/a
6 days ago
+29.35%
Biodexa shares are trading higher after the compan...
Unlock content with
Pro Subscription
1 month ago
+6.92%
Biodexa Pharmaceuticals shares are trading higher after the company announced it has been awarded a $3 million grant from CPRIT to support the registrational Phase 3 program of eRapa in familial adenomatous polyposis.
